| 摘要 |
PROBLEM TO BE SOLVED: To provide a new adjuvant for ophthalmologic operation capable of easily performing a hemostatic treatment in the operation, lessening the burden on a patient or an operator and reducing the incidence of iatogenic retina hiatus in the operation. SOLUTION: This ophthalmologic operation adjuvant is characterized by comprising (2R,4R)-4-methyl-1-[N2(RS)-3-methyl-1,2,3,4-tetrahydro-8- quinolinesulfonyl-L-alginyl]-2-piperidinecarboxylic acid, its hydrate or a pharmaceutically permissible salt thereof.
|
